Earlier quoted context omitted.
Yes those drugs. Hard to say conclusively, but the failure of most of CETP inhibitors is troubling news for the hyperlipidemia theory. Meaning possible hyperlipidemia has multiple causes and in and of itself isn't bad. AKA Cause A results in hyperlipidemia. Cause B results in hyperlipidemia. Cause C results in hyperlipidemia and arterial plaques. Cause D results in hyperlipidemia.
Numerous lines of evidence, including randomized controlled trials, single gene studies, and Mendelian randomization studies, are not consistent with your interpretation. Multiple agents that reduce cholesterol, including ezetemibe and statins, reduce cardiovascular disease outcomes and death. Multiple cholesterol-related genes, including HMGCR, LDLR, APOB, PCSK9, and ANGPTL3, contain variants which influence both LD…
Only in small selected populations.